DCAT Value Chain Insights’ Production to Prescription

DCAT
DCAT Value Chain Insights’ Production to Prescription

DCAT Value Chain Insights' Production to Prescription podcast, presented by the Drug, Chemical & Associated Technologies Association (DCAT), features thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance.

  1. 30/12/2024

    Bio/Pharma Industry Outlook, Supply Chains 2025: The Year Ahead

    What will be the key issues shaping bio/pharma supply chains in 2025? Looking at the impact of potential changes in US tariff and trade policy. Plus, what lies ahead in product-specific supply chains for sterile injectables and antibody drug conjugates. And the latest on how companies are advancing upstream supplier risk monitoring and predictive risk planning, including through digitalization and AI. Featuring: Derron Stark, EY-Parthenon Partner, Strategy & Transactions – Health Sc...

    25 min

  2. 22/02/2024

    What’s Trending: Parenteral Drug Development & Manufacturing

    What are some key trends and issues arising in parenteral drug development and manufacturing? From more complex molecules and modalities and sterile drug-product capacity market shifts, DCAT Value Chain Insights takes an inside look. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above) Major trends in parenteral drug development Long peptides in NDAs and BLAs New complex modalities Sterile drug-pro...

    16 min

  3. 21/12/2023

    CDMOs/CMOs: The Movers and Shakers of 2023

    As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the headlines this year and the leading moves they made. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above) BaxterSamsung BiologicsLotte BiologicsFujifilm Diosynth BiotechnologiesLonza CambrexExpansions in peptides, oligonucleotides&nb...

    28 min

  4. 14/06/2023

    CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023

    As we near the mid-year mark, what have been the key moves—mergers and acquisitions, expansions, and new CDMOs entering the market—thus far in 2023? DCAT Value Chain Insights takes an inside look on what is on the industry’s radar. For the text version of this article visit dcatvci.org. Key topics: (see Chapter Markers in drop down menu in audio player above) BaxterLarge-scale biomanufacturing expansions continue Samsung BiologicsLotte BiologicsFujifilm Diosynth BiotechnologiesLonza...

    23 min

  5. 02/05/2023

    API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains

    The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages and secure supply chains. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above) Proposed reforms Security of supply and supply-chain reforms Specific proposals Podcast Sponsor: BIOVECTRALinks: Subs...

    14 min

  6. 16/11/2022

    The CDMO/CMO Report: Parenteral Drugs

    Increased demand in biologic-based drug development is a key factor driving demand for parenteral drug manufacturing. What are key trends and expansions by CDMO/CMOs in parenteral drug manufacturing? DCAT Value Chain Insights rounds up the latest developments among CDMO/CMOs. For the text version of this article visit dcatvci.org. Key topics: (see Chapter Markers in drop down menu in audio player above) Recent expansion projects Baxter BioPharma Solutions Vetter Recip...

    31 min

  7. 17/08/2022

    Drug Products: Key Trends & Recent Approvals

    What are noteworthy trends in drug delivery and drug-product development in key dosage forms: solid dosage and parenteral drugs? A look at key technology advances and recent new drug approvals. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above)Recent trends: new drug approvalsTechnology advancesEnable Injections’ on-body subcutaneous drug-delivery systemLilly’s and Triastek’s pact for 3-D printing for oral drug deli...

    12 min

  8. 14/07/2022

    CDMOs/CMOs Expand High-Potency API Manufacturing

    Growth in the oncology drug market continues to spur demand for high-potency API manufacturing. Which CDMOs/CMOs are expanding? DCAT Value Chain Insights rounds up the latest investments. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above)A roundup of recent investments in HPAPI manufacturing WuXi STA MilliporeSigmaPiramal Pharma SolutionsCambrexHAS Healthcare Advanced SynthesisAGC Fine ChemicalsLonzaCarbog...

    22 min
See All (45)

About

DCAT Value Chain Insights' Production to Prescription podcast, presented by the Drug, Chemical & Associated Technologies Association (DCAT), features thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance.

Information

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada